Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes
- 21 December 2001
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 33 (3) , 310-321
- https://doi.org/10.1002/gcc.10026
Abstract
In this investigation, we selected PAX3/FKHR and PAX7/FKHR fusion transcript–positive and –negative alveolar rhabdomyosarcomas (ARMSs) and embryonal rhabdomyosarcomas (ERMSs) with and without anaplastic features, to ascertain genomic imbalance differences and/or similarities within these histopathologic and genetic rhabdomyosarcoma (RMS) variants. Comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) studies were performed on 45 rhabdomyosarcoma specimens consisting of 23 ARMSs and 22 ERMSs (12 ERMS cases were included from an earlier study). The anaplastic variant of RMS has not previously been subjected to CGH analysis. Overall, the most prominent imbalances were gain of chromosomes or chromosomal regions 2/2q (40%), 7/7q (31%), 8/8p (53%), 11/11q (31%), 12q13‐15 (49%), 13q14 (22%), and 20/20p (31%), and loss of 1p36 (27%), 3p14‐21 (22%), 9q21‐22 (33%), 10q22‐qter (18%), 16q (27%), 17p (22%), and 22 (22%). These gains and losses were distributed equally between ARMS and ERMS histologic subtypes (excluding 7/7q and 11/11q gain that were observed chiefly in ERMS), demonstrating that these entities are similar with respect to recurrent genomic imbalances. Moreover, genomic imbalances were also evenly distributed among the ARMS fusion transcript subtypes, providing evidence for a genetic kinship despite the absence of a fusion transcript in some cases. Genomic amplification was detected in 26% and 23% of the ARMS and ERMS cases, respectively (with nearly all of the latter subset exhibiting anaplastic features). One amplicon, involving 15q25‐26, corresponds to the locus of the insulin‐like growth factor type I receptor (IGF1R) gene. Amplification of IGF1R was confirmed molecularly in the cases exhibiting a 15q25‐26 amplicon. In summary, these results indicate that genomic gains and losses involve alike chromosomes with similar frequencies within the histopathologic and genetic subtypes of rhabdomyosarcoma, that genomic amplification is frequent not only in the alveolar histologic subtype of rhabdomyosarcoma but also in ERMS with anaplasia, and that amplification of IGF1R possibly plays a role in the development or progression of a subset of rhabdomyosarcomas.Keywords
This publication has 28 references indexed in Scilit:
- Molecular Characterization of the Genomic Breakpoint Junction in the t(11;18) (q21;q21) Translocation of a Gastric MALT LymphomaBiochemical and Biophysical Research Communications, 2001
- Regulation of the Insulin-Like Growth Factor-I Receptor Gene by Oncogenes and Antioncogenes: Implications in Human CancerMolecular Genetics and Metabolism, 2000
- Diminished G1 Checkpoint after γ-Irradiation and Altered Cell Cycle Regulation by Insulin-like Growth Factor II OverexpressionPublished by Elsevier ,1999
- Embryonal Rhabdomyosarcoma with Only Numerical Chromosome Changes: Case Report and Review of the LiteratureCancer Genetics and Cytogenetics, 1999
- A YAC-Based Transcript Map of Human Chromosome 9q22.1–q22.3 Encompassing the Loci for Hereditary Sensory Neuropathy Type I and Multiple Self-Healing Squamous EpitheliomaGenomics, 1998
- GENE ALTERATIONS AND APOPTOSIS IN RHABDOMYOSARCOMAPediatric Pathology & Laboratory Medicine, 1997
- Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.Journal of Clinical Investigation, 1994
- Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumorsGenes, Chromosomes and Cancer, 1994
- Amplification of the anonymous marker D17S67 in malignant astrocytomasGenes, Chromosomes and Cancer, 1994
- Childhood Rhabdomyosarocoma with Anaplastic (Pleomorphic) FeaturesThe American Journal of Surgical Pathology, 1993